CD274 and diffuse large B-cell lymphoma: Meanwhile, DLBCL patients with a higher expression level of PD-L1 seem to show a correlation with an increased resistance to frontline therapy but always related to prolonged PFS if treated with anti-PD-1 antibody (El Hussein et al., 2020; Wang L. et al., 2020).